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Objective: Bone marrow stimulation (BMS) has been regarded as a ﬁrst line procedure for repair of
articular cartilage. However, repaired cartilage from BMS is known to be unlike that of hyaline cartilage
and its inner endurance is not guaranteed. The reason presumably came from a shortage of cartilage-
forming cells in blood clots derived by BMS. In order to increase repairable cellularity, the feasibility
of autologous bone marrow-derived buffy coat transplantation in repair of large full-thickness cartilage
defects was investigated in this study.
Methods: Rabbits were divided into four groups: the defect remained untreated as a negative control;
performance of BMS only (BMS group); BMS followed by supplementation of autologous bone marrow
buffy coat (Buffy coat group); transplantation of autologous osteochondral transplantation (AOTS) as
a positive control.
Results: Repair of cartilage defects in the Buffy coat group in a rabbit model was more effective than BMS
alone and similar to AOTS. Gross ﬁndings, histological analysis, histological scoring, immunohisto-
chemistry, and chemical assay demonstrated that supplementation of autologous bone marrow buffy
coat after BMS arthroplasty effectively repaired cartilage defects in a rabbit model, and was more
effective than BMS arthroplasty alone.
Conclusion: Supplementation of autologous bone marrow-derived buffy coat in cases of BMS could be
a useful clinical protocol for cartilage repair.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular cartilage is a resilient load-bearing tissue that forms
the articulating surface of diarthrodial joints and provides low
friction, lubrication, and wearless characteristics necessary for
repetitive gliding motion. However, because articular cartilage has
neither vascular nor lymphatic channel supply and hence difﬁcult
access to stem cells, its self-healing potential is restricted1,2.
Additionally low cell mobility due to surrounding matrix and
a limited number of progenitor cells could be another contributing: B.-H. Min, Department of
ersity, San5, Wonchondong,
orea. Tel: 82-31-888-6201;
s Research Society International. Pfactors3. Until now, much effort has been placed on development of
therapeutic approaches for cartilage repair.
Among the various strategies at present, the bone marrow
stimulation (BMS) technique is one that has widely been used for
repair of articular cartilage defects. This approach is aimed at
creation of a suitable environment for new tissue formation, and
utilization of the intrinsic healing ability of the body. BMS recruits
mesenchymal stem cells (MSCs) or progenitor cells via subchondral
penetration to the bone marrow, thereby stimulating cartilage
repair. However, it was observed that ﬁbrocartilaginous tissue with
poor mechanical properties was obtained instead of the desired
hyaline cartilage. This observation is likely a result of excessive
loading conditions and a limited number of reparative MSCs
available due to loss and dilution of bone marrow originated blood
clots from the BMS region caused by the synovial ﬂuid. To overcome
this problem, some approaches to prevent leakage of bone marrow
stem cells from the defect have been investigated. Breinan et al.ublished by Elsevier Ltd. All rights reserved.
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of the microfracture technique in order to minimize the ﬂow of
bone marrow into the joint cavity4. Consequently, cartilage repair
was better in the group with the covered defect compared to the
groupwith the defect left exposed. In another approach, Taner et al.
covered the defective cartilage area with autologous periosteum
membrane following microfracture, and ﬁxed the leg with an
assistive device for reduction of overloading5. Breinan reported that
addition of cultured autologous chondrocytes results in the same
tissue types as those yielded by microfracture treatment4.
In our previous study, a larger number of MSC drained from
bone marrow produced a better quality of repaired cartilage in the
defect6. Therefore, the effort to enhance the intrinsic cells should be
exerted in order to obtain a more hyaline-like cartilage.
Bone marrow is known to contain multipotent stem cells that
can differentiate not only into hematopoietic cells, but also into
mesenchymal tissue. Azizi et al. reported that several investigators
who are treating various intractable diseases (including ischemic
myocardial diseases, osteogenesis imperfect, Duchenne’s muscular
dystrophy, and central nervous system disorders, such as Parkin-
son’s disease) are focusing on the use of bone marrow stem cells7.
Many studies have reported on the therapeutic potential of bone
marrow-derived mononuclear cells for regeneration of various
types of tissues8. These cells have been used for treatment of
non-traumatic avascular necrosis of the femoral head9, infarction of
the myocardium10, and cartilage damage11 and have also been
applied to a continuous spinal fusion mass12. In terms of cartilage
repair, as bone marrow mononuclear cells (MNCs) can be
fractionated to contain higher proportion of MSCs, they can
potentially be used after microfracture to provide more MSCs in the
defect area11,12.Fig. 1. Procedure for implantation of autologous buffy coat. Bone marrow was aspirated fro
a Ficoll gradient centrifugation system and injected into the BMS treated area of articular cIn this study, we hypothesized that implantation of autologous
uncultured bone marrow cells from buffy coat into a full-thickness
articular cartilage defect would generate tissue that more closely
resembles hyaline cartilage. Extracellular matrix (ECM) membrane
(ArtiFilm, Regenprime Co., Ltd, Korea) was used to prevent leakage
of injected cells and blood clots from the cartilage defect into the
knee joint cavity.
Materials and methods
Experimental design and surgery
Use of animals in this experiment was approved by the Institu-
tional Animal Experiment Committee of Ajou University. Seventy-
two New Zealand white rabbits of 16 weeks old (an average
weight of 3.0e3.5 kg) at which the growth plates are already closed
were used in this study. Surgical procedures, including limb prepa-
ration and draping, were performed under general anesthesia with
a mixture (0.2 ml/kg body weight) of Zoletil (50 mg/ml; Virbac
Laoratoires-06516 Carros, France) and xylazine hydrochloride
(Rompun; Bayer, Ansan, Korea) (Zoletil:Lompun¼ 1:2). An arthrot-
omy was made through a midline longitudinal incision on the
medial parapatellar with the patella dislocated laterally to expose
the femoral condyle. A drill 5 mm in diameter was used for creation
of an osteochondral defect of 2 mm in depth in the patella groove13.
BMS was performed using a 5 mm drill and 17-gauge needle.
For the in vivo study, we used a natural ECM membrane
(ArtiFilm, Regenprime Co., Ltd, Korea) derived from cultured
young porcine chondrocytes to cover the cartilage defect (Fig. 1).
ArtiFilm was fabricated by decellularizing a membrane-type
cell/ECM composite produced by high density culture of porcinem rabbit iliac crest. Then, 20 ml of buffy coat was separated from bone marrow using
artilage, followed by ECM membrane covering.
Table I
Comparison of MSC frequencies between blood clot obtained from the BMS region
and bone marrow obtained from the iliac crest. There was no difference in MSC
frequency; however, as the achieved volume of bone marrow (4 ml) is bigger than
the volume of the blood clot (40 ml) by 100 times, a centuple number of MSCs could











39.25 9.8 23.88 5.96 608.3 151.88
Bone marrow
from iliac crest
4,000 500 2,431.2 270.8 607.8 175.98 9.2 3.9 106
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ECM components such as type II collagen and sulfated glycosami-
noglycans (GAGs). The study group was divided at random into four
groups (n¼ 18/group): (1) the defect was left untreated as a nega-
tive control (Defect group), (2) treated with BMS using a 17-gauge
needle after making the osteochondral defect using a 5 mm drill
(BMS group), (3) supplemented concentrated autologous buffy coat
was isolated from the iliac crest after BMS (Buffy coat group) and (4)
implanted with an autologous osteochondral graft (AOTS) as
a positive control. In this study, the AOTS group was set up by re-
inserting autologous osteochondral tissues isolated when making
osteochondral defect using the AOTS system (Autograft diameter
6 mm, Arthrex, Germany)14. Cartilage defects in the Defect, BMS,
and Buffy coat groups were subsequently covered with an ECM
membrane with ﬁxation using the cross suture method. Each
operated knee joint was immobilized with an assistive device post-
surgery. Repair of cartilage was evaluated by macroscopic, histo-
logical and immunohistochemical analyses for repaired tissues at 4
and 8 weeks post-operation and additionally by biochemical
analysis for repaired tissues at 8-week post-operation.
The description on the experimental design is based on Animals
in Research: Reporting In vivo Experiments (ARRIVE) guidelines15.
Measurement of the number of MSC drained by the BMS technique
and harvested at the iliac crest
Colony forming unit-ﬁbroblast (CFU-F) analysis was performed
for measurement of the number of MSCs present in bone marrow
isolated from the iliac crest or blood clots after BMS on the cartilage
defect. Brieﬂy, 4 ml of bone marrow blood was harvested from the
iliac crest and 100 ml of blood was drained from cartilage defects by
microfracture. The samples were diluted in PBS and the buffy coat
was isolated by centrifugation using a Ficoll density gradient
(Amersham Biosciences, 17-1440-02, Sweden) at 1,000g for
30 min16. A total of 1 ml of buffy coat in serum was isolated from
this suspension, and then concentrated into 20 ml. The buffy coat
was resuspended in MSC culture medium consisting of a-MEM
supplemented with 10% FBS, and subsequently plated in 6-well
culture dishes. Bone marrow harvested from the blood clot
obtained after BMS was resuspended in the same manner. After
6 days, non-adherent cells were discarded and adherent cells were
replenished with fresh medium after washing. The cells were then
cultured for about 12 days, with replacement of the culture
medium every 3 days, and stained with 5% crystal violet solution in
100% methanol for 10 min for the CFU-F assay17. To minimize the
effects of subjective bias three researchers counted the number of
colonies greater than 2 mm in diameter in the blind manner.
Macroscopic and histological evaluations
At 4 and 8 weeks after surgery, the rabbits were euthanized by
injection of an over-dose of pentobarbital. Femoral condyles were
subsequently retrieved. Macroscopic images of the condyles were
ﬁrstobserved; the sampleswere thenparafﬁn-embedded, sectioned,
and processed for routine safranin-O, Sirius red staining and
immunohistochemical analysis18. For immunohistochemical anal-
ysis, the sectionswere incubatedwithmousemonoclonal anti-rabbit
collagen type II antibody (Chemicon, Temecula, CA, USA) at 1:200
dilution for 1 h at room temperature. The sections were then incu-
bated sequentially with biotinylated secondary antibody at 1:200
dilutions for 1 h andperoxidase-conjugated streptavidin solution for
30 min at room temperature (DAKO LSAB System, Carpinteria, CA,
USA). After counterstaining with Mayer’s hematoxylin (Sigma,
St Louis,MO,USA), the sectionsweremountedwithamount solution
prior to microscopic observation (Nikon E600, Japan)19,20.Histological scoring [International Cartilage Repair Society Score
(ICRS)]
To minimize the effects of subjective bias three researchers
independently evaluated the quality of the repaired articular carti-
lage in the defects, and amodiﬁed version of thehistological grading
scale system was used for the ICRS score19e21. The scale consists of
seven categories and assigns a score ranging from 0 to 18.
Chemical assay of repaired tissue
For chemical assays of the repaired tissue, samples were har-
vested from the defect by surgical knife and curette. The harvested
tissue was dried and digested in papain solution (5 mM L-cysteine,
100 mM Na2HPO4, pH 6.4, 5 mM EDTA, and 125 mg/ml papain type
III) at 60C for 24 h and then centrifuged at 12,000g for 10 min. For
measurement of the GAG contents, the supernatant was subjected
to 1,9-Dimethylmethylene Blue (DMB) colorimetric assay. DNA
content was measured using a Qubit Fluorometer and the protocol
given by the supplier (Invitrogen, Eugene, OR, USA)20e22. In all
assays, normal cartilage from rabbit knee was used as a control.
GAG contents were determined using chondroitin sulfate from
shark cartilage (Sigma) as a standard17e19.
Statistical analysis
Statistical analysis of the experimental data was carried out
using one-way analysis of variance (one-way ANOVA) for multiple
comparison and speciﬁc inter-data differences between mean
values were identiﬁed using the Tukey-HSD test. P values less than
0.05 were regarded statistically signiﬁcant and described in Results.
Results
CFU-F assay
Crystal violet staining showed that there was no signiﬁcant
difference in the number of MSC colonies between the same
volume of blood clot located in the BMS region and harvested from
the iliac crest. Average blood volume and number of MSCs after
BMS in the cartilage defect area were 39.25 9.8 ml and
23.88 5.96 MSCs, respectively. The mean volumes of bone
marrow and number of MSCs aspirated from the iliac crest were
4 ml and 2,431.2 270.8 MSCs, respectively (Table I).
Gross ﬁndings and histological evaluation of cartilage defects
At week 4 after surgery, the defect area in the Defect group
remained vacant while in the AOTS group, the defect was
completely ﬁlled with smooth and glistening tissue. Repaired
tissues in the BMS group partially ﬁlled the defect area and the
extent of ﬁlling of the defect was much wider in the Buffy coat
Fig. 2. Gross observation of the defect area of the cartilage at 4 weeks (AeD) and 8 weeks (EeH) after surgery. In the 4-week samples, C and D showed a smooth and glistening
appearance, and continuity with the surrounding host cartilage tissue was also observed. In contrast, the defect was not repaired in picture A and was ﬁlled partially with ﬁbrous
tissues in picture B. At 8 weeks after surgery, a white and glistening appearance of repaired tissues was shown in all groups. Histological observation of repaired cartilage in the
defect area of the experimental groups at 4 weeks (IeP) and 8 weeks (QeX) after surgery. And Safranin-O staining image of normal cartilage was also provided (Y). The defect was
partially ﬁlled with ﬁbrous tissues in the Defect and BMS groups at week 4. In contrast, hyaline cartilage-like tissues were observed partially in the Buffy coat group and completely
in the AOTS group. At week 8, ﬁbrous/hyaline cartilage was regenerated in the Defect and the BMS groups. In contrast, hyaline cartilage tissues with mature matrix and columnar
organization of chondrocytes were observed in the Buffy coat and AOTS groups. Magniﬁcation was 20 (IeL, QeT, Y), and 200 (MeP, UeZ).
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guished from the surrounding cartilage. At week 8, defects in all
groups, except for the AOTS group, were observed to be ﬁlled with
repaired tissue, but appeared different from the surrounding
cartilage because of their white color. In the AOTS group, the defect
area was ﬁlled with tissue that was indistinguishable from normal
cartilage [Fig. 2(AeH)].
Safranin-O staining showed that defects in the Defect group
were partially ﬁlled with ﬁbrous tissue, while those in the AOTS
group appeared to have normal cartilage, which had meta-
chromatically stained ECM with well-aligned cells. However, graft
tissue was not integrated with host tissue. In the BMS group,
defects were ﬁlled with ﬁbrous tissue minimally occupied with
hyaline-like tissues at week 4. In contrast, most tissue, except for
the surface layer, stained with safranin-O; however, its surface was
quite rough and cells generally lacked orientation in the Buffy coat
group. None of the groups, except for the AOTS group, showed
subchondral bone remodeling. At week 8, ﬁbrous tissue was ﬁlled
in the Defect group, while the AOTS group showed good appear-
ance of hyaline cartilage without evidence of degenerative change
around the defect area. However, graft tissue still did not integrate
with host tissue. Repaired tissue in the BMS group showed an
increased area of metachromatic staining compared to that of
4 weeks; however, it was still occupied by much ﬁbrous-like tissue
covering the articular surface. In the Buffy coat group, repaired
tissue was well organized with intense ECM; further, the cell
distribution was composed of columnar and cluster cells with
hyaline character, even though its surface and cartilage-bone were
irregular. Except for the AOTS group, none of the groups showed the
tide mark and columnar arrangement of cells [Fig. 2(IeZ)].
In Sirius red staining, collagen ﬁber was found only in small
amounts in samples of the Defect and BMS groups at week 4, and
no oriented pattern was observed. Collagen ﬁbers were found inFig. 3. Sirius red staining image at 4 weeks (AeH) and 8 weeks (IeP) after surgery. An im
and 200 (EeH, MeP), respectively.large amounts in the Buffy coat group. In the AOTS group, oriented
collagen ﬁbers perpendicular to the cartilage surface were found;
however, integration was not observed between implanted carti-
lage tissue and host cartilage. At week 8 after surgery, the amount
of collagen ﬁbers was increased in all groups; however, oriented
arrangement of collagen ﬁbers was not observed in the Defect and
BMS groups. In the Buffy coat and AOTS groups, a well-oriented
arrangement of collagen ﬁbers similar to normal cartilage were
found at 8 weeks; however, integration between implanted tissue
and host tissue was also not observed (Fig. 3).
The ICRS histological score showed signiﬁcant improvement
with time in all but the AOTS group. It was not until 8 weeks that
the Buffy coat group and the BMS group showed a difference in ICRS
score (Number of femoral condyles (N) 5, P< 0.001.018,
P< 0.001) (Fig. 4).
Expression of type II collagens
Expression of type II collagen increased gradually with time at
the pericellular region in the repaired tissue of the BMS, Buffy coat,
and AOTS groups. Collagen was diffusely distributed in territorial
regions, as well as the pericellular area at week 4 in the BMS and
Buffy groups. It was reorganized to converge into the pericellular
area along with chondrocytes, similar to the AOT group at week 8.
The Defect group showed minimal deposition of collagen, even at
week 8 (Fig. 5).
Chemical assay of repaired tissue
At 8 weeks post-surgery, the amount of GAG in the Buffy group
was signiﬁcantly higher than those in the Defect and BMS groups,
but not as much as in the AOTS and Normal groups, while there was
no statistically signiﬁcant difference in the amount of GAG in theage of normal cartilage was also provided (Q). Magniﬁcation was at 100 (AeD, IeL)
Fig. 4. ICRS scores at 4 weeks and 8 weeks after surgery. The total ICRS histological
score increased signiﬁcantly along with time in all groups. No signiﬁcant difference
was observed between the Buffy coat group and the BMS group at 4 weeks; however,
at 8 weeks, a signiﬁcant difference was shown in ICRS score. N 5, P¼ 0.018, P¼ 0.
(Error bars are standard deviation, *P< 0.05).
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suggested that GAG formation of the Buffy coat group approached
that of normal cartilage (N 5, P< 0.001.015, P< 0.001.047)
[Fig. 6(A)]. Lower levels of DNA content were detected in the Buffy
coat group compared to the Defect and BMS groups. On the other
hand, the AOTS and Normal groups did not show the signiﬁcant
difference. This ﬁnding means that repaired cartilage of the
Buffy coat group was compatible to hyaline cartilage (N 5,
P< 0.001.045, P< 0.001) [Fig. 6(B)].Fig. 5. Immunohistochemistry for collagen type II expression. At 4 weeks (AeH) and 8 weeks
of 20: AeD, IeL and magniﬁcation of 200: EeH, MeP) Expression of type II collagen was
BMS, Buffy coat, and AOTS groups. It was not signiﬁcantly detected in the Defect group at b
color was observed in zonal-structure in the Buffy coat and AOTS groups at 8 weeks.Discussion
We hypothesized that implantation of buffy coat provides a large
number of bone marrow stem cells and other biochemical factors,
and, in turn, can signiﬁcantly enhance repair of cartilage defects.
Several aspects of the results from this study support the hypothesis.
Gross morphology of repaired tissue in the autologous buffy coat-
supplemented group (Buffy coat group) resembled that of normal
cartilage, having a glistening appearance in the defect area. In addi-
tion, hyaline cartilage-like tissue with mature matrix and columnar
organization of chondrocytes was observed by histological evalua-
tion. Similarly, the chemical assay showed that the GAG component
in repaired tissue is almost the same as that in normal cartilage.
The amount of blood clots is not much after BMS. In addition,
most of the blood clots consisted of blood cells that were less likely
related to tissue regeneration, and the number of stem cells was
only hundreds per mm3 in defect area6. Given the fact that the
number of chondrocytes in healthy cartilage is 100,000/mm3, the
number of stem cells obtained through BMS is relatively low23. The
small number of MSCs may be a factor in the inclination of cartilage
repair toward ﬁbrocartilage after BMS. We found that an average of
only 39.25 ml blood ﬂowed out from the bone marrow through the
BMS, which contained 23.88 MSCs (Table I) while 4 ml of bone
marrow blood could be obtained at our discretion from the iliac
crest, of which buffy coat contained approximately 2,431.2 MSCs
(Table I). In the rabbit bone marrow, the MSCs frequency of the
ﬁcoll-isolated buffy coat (2.43 per 104 MNCs) was similar to that of
the human bone marrow ranging 1 per 103e105 MNCs24. Resul-
tantly, total number of MSCs in the defect area drastically increased
with addition of buffy coat (approximately 2,400 MSCs). Therefore,(IeP) after surgery. An image of normal cartilage was also provided (Q). (Magniﬁcation
gradually increased along with time at the pericellular region in repaired tissues of the
oth week 4 and 8. The most signiﬁcant expression of type II collagen with dark brown
Fig. 6. (A) Changes and comparison of GAG contents among the experimental groups at 8 weeks after surgery. GAG contents of the Buffy coat group were higher than those of the
Defect group and the BMS group. Moreover, they were signiﬁcantly different in statistical analysis. However, the Buffy coat group showed no difference from those of the AOTS
group and normal groups in statistical analysis. N 5, P¼ 0.015, P¼ 0.047. (B) Changes and comparison of DNA contents among the experimental groups at 8 weeks after surgery. A
lower level of DNA content was detected in the Buffy coat group compared with the Defect group and the BMS group. Moreover, they were signiﬁcantly different in statistical
analysis. However, the Buffy coat group showed no difference from those of the AOTS group and normal groups in statistical analysis. N 5, P¼ 0.045, P¼ 0. (Error bars are standard
deviation, *P< 0.05).
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a larger number of cells. In the present study, we showed that
implantation of autologous bone marrow buffy coat after BMS
arthroplasty was more effective than the BMS alone and regen-
erated efﬁciently the cartilage defects in a rabbit model. Based upon
the results of this study, the appropriate amount of buffy coat to be
collected from the bone marrow when this technique is applied to
a human subject can be approximated. In this study, the cartilage
defect was 5 mm in diameter and 2 mm in depth, and its volume
was approximately 40 ml, while buffy coat was approximately 20 ml.
In case, for a human cartilage defect that is 10 mm in diameter and
4 mm in depth, 157 ml of buffy coat from 31 ml of bone marrow
seems appropriate for the therapy.
More MSCs may be transplanted by extracting a lot of blood
from the bone marrow and concentrating it. Hernigou et al. and
Kasten et al. gained 108 CFU-Fs/ml and 1,480 CFU-Fs/ml in 306 ml
and 297 ml aspirate, respectively, and ﬁnally concentrated them
into 612 CFU-Fs/ml in 20 ml(4 times) and 2,579 CFU-Fs/ml in 18 ml
(14 times) by decreasing the volume25,26. It is of note that the
concentrated bone marrow aspirates were shown to repair osteo-
chondral defect in a large animal of equine model27. Transplant of
buffy coat has some advantages compared to the transplant of
cultivated MSC. Transplant of autologous cell requires two steps for
harvesting the patient’s cell or tissue and transplanting after
cultivation. In contrast, the transplant of buffy coat can be ﬁnished
at a time without cultivation as well as reduce chance of contam-
ination derived from it. In addition, it will reduce the cost of
cultivation drastically.
Many reports have shown that bonemarrow-derivedMSCs have
a high potential for the repair of mesenchymal tissue28. However,
Matsumoto et al. reported that the cultured MSCs transplanted in
the cartilage defect regenerated it but formed ﬁbrocartilage29.
Besides, uncultured MNCs that include both MSCs and HSCs, and
the buffy coat have also been used widely as a cell source for
cartilage regeneration9e12. MNCs or buffy coat can be used imme-
diately without any risk related to their culture in vitro. It is also
believed that T cells, B cells, macrophages, and cytokines that are
secreted by platelets in buffy coat may inﬂuence defect healing.
One possible reason for the occurrence of ﬁbro-cartilage repair
is that bone marrow and blood clots could have been washed away
by ﬂuid within the knee joint cavity. To overcome this problem, the
ECM membrane (ArtiFilm) made by cultured porcine chondrocytes
was used in this study. The ECM membrane is comprised mainly of
cartilage-enriched ECM molecules such as collagen type II and
sulfated GAGs, and previously shown to have high biocompatibility,biodegradability, and cartilage afﬁnity30. We speculate that the
ECMmembrane presumably can not only cover the cartilage defect
to prevent loss of cells in the defect area, but can also interrupt
inﬂuence from synovial ﬂuid in order to prevent differentiation of
stem cells in an unwanted direction30. Additionally it is very thin
(approximately 30 mm) not to be caught in articulation. Accord-
ingly, it is regarded as a suitable biomaterial for cartilage repair.
Similar to our study, a collagen type I/III membrane has been also
used recently to protect autologous bone marrow and successfully
repair the cartilage defect31.
It is widely accepted that scaffold biomaterials can also inﬂuence
signiﬁcantly the cartilage repair32. Because this study was designed
to address the effect of BM-derived buffy coat, the ECM membrane
was applied to all experimental groups to simply cover the defect
area and prevent possible loss of MSCs.We speculate, however, that
the ECM membrane could provide cells with a cartilage-like and
favorable environment for cartilage repair. Although we have no
direct results using the ECM membrane, a 3D scaffold made of the
same ECM material was previously shown to be much superior to
poly glycolic acid (PGA) scaffold in supporting cartilage tissue
formation using chondrocytes and chondrogenesis of bone marrow
MSCs in vitro13,33. Therefore, the ECM membrane could be a better
choice over other biomaterial scaffolds for the cartilage repair.
Though AOT has been shown to lead cartilage regeneration fairly
well in human or animal models, transplanted tissues have still
problems arisen from different thickness and collagen ﬁber direc-
tion from surrounding ones. In this study, we set up new AOT
protocol by inserting the isolated osteochondral tissue from the
osteochondral defect back into its own site. It is expected to be
optimal since the thickness and direction of collagen ﬁber of
a transplanted tissue ﬁts well into the surrounding tissues.
A major limitation of this study is that we did not compare
implantation of buffy coat only without performance of micro-
fracture. Because the number of MSCs from buffy coat was over-
whelming that by microfracture, the effect of microfracture may be
abolished. However, we speculate that in order to prove this
concept, we should design another set of experiments for evalua-
tion of the effect of microfracture, that is to say, the role of sub-
chondral bone as a holder of blood clot or foundation to support
repair of cartilage.
Conclusion
We observe that implantation of autologous bone marrow buffy
coat after BMS repair of the cartilage defect in a rabbit model is
L.H. Jin et al. / Osteoarthritis and Cartilage 19 (2011) 1440e1448 1447better than BMS alone. It is postulated that the implanted buffy coat
provides a larger number of MSCs and plausible supporting
humoral factors for repair of the defect and that the ECM
membrane covering the defect played a role in prevention of the
injected cells and blood clot from leaking into the joint ﬂuid. As the
method employed in this study is safe and easy, it is potentially
feasible for clinical applications.Author contributions
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